AR026704A1 - Forma cristalina - Google Patents
Forma cristalinaInfo
- Publication number
- AR026704A1 AR026704A1 ARP000106383A ARP000106383A AR026704A1 AR 026704 A1 AR026704 A1 AR 026704A1 AR P000106383 A ARP000106383 A AR P000106383A AR P000106383 A ARP000106383 A AR P000106383A AR 026704 A1 AR026704 A1 AR 026704A1
- Authority
- AR
- Argentina
- Prior art keywords
- compound
- refers
- pharmaceutically acceptable
- crystalline form
- solvate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
- C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente se refiere a las formas cristalinas del compuesto ácido 3-{4-[2-(4-terc-butoxicarbonilaminofenil)etoxi}fenil}-(S)-2-etoxi propanoico, segunformula (1) o su sal farmacéuticamente aceptable, y cualquiera de sus solvatos. La presente también se refiere a los métodos para tratar una o más enfermedadesmetabolicas, particularmente aquellas asociadas con el Síndrome de Resistencia a la Insulina, y el uso de la forma cristalina del compuesto, o su salfarmacéuticamente aceptable, o su solvato , para la fabricacion de un medicamento para uso terapéutico en una o más enfermedades metabolicas. La presente ademásse refiere a las composiciones farmacéuticas que contienen a la forma cristalina del compuesto, o su sal farmacéuticamente aceptable , o su solvato, comoingrediente activo, así como también a los procesos para la fabricacion de la forma cristalina del compuesto, o su sal farmacéuticamente aceptable, o susolvato.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9904417A SE9904417D0 (sv) | 1999-12-03 | 1999-12-03 | Crystalline form |
| SE0001422A SE0001422D0 (sv) | 2000-04-17 | 2000-04-17 | Crystalline form |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR026704A1 true AR026704A1 (es) | 2003-02-26 |
Family
ID=26655079
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP000106383A AR026704A1 (es) | 1999-12-03 | 2000-12-01 | Forma cristalina |
Country Status (3)
| Country | Link |
|---|---|
| AR (1) | AR026704A1 (es) |
| AU (1) | AU2034601A (es) |
| WO (1) | WO2001040165A1 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100517644B1 (ko) | 1997-10-27 | 2005-09-28 | 닥터 레디스 레보러터리즈 리미티드 | 신규의 삼원 화합물 및 그 약학적 용도, 그 제조방법 및이들을 포함하는 약제학적 조성물 |
| US6440961B1 (en) | 1997-10-27 | 2002-08-27 | Dr. Reddy's Research Foundation | Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them |
| CA2307068C (en) | 1997-10-27 | 2007-04-10 | Dr. Reddy's Research Foundation | Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| US6369067B1 (en) | 1997-10-27 | 2002-04-09 | Dr. Reddy's Research Foundation | Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them |
| US6130214A (en) | 1997-10-27 | 2000-10-10 | Dr. Reddy's Research Foundation | Benzothiazin and benzoxazin derivatives; their preparation and uses |
| HUP0104193A3 (en) | 1998-10-29 | 2003-07-28 | Reddys Lab Ltd Dr | An improved process for the preparation of new antidiabetic agents |
| US6531596B1 (en) | 1998-10-29 | 2003-03-11 | Dr. Reddy's Laboratories Ltd. | Process for the preparation of new antidiabetic agents |
| US6897199B2 (en) | 2001-02-05 | 2005-05-24 | Dr. Reddy's Laboratories Ltd. | Pharmaceutically acceptable salts of phenoxazine and phenothiazine compounds |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9801990D0 (sv) * | 1998-06-04 | 1998-06-04 | Astra Ab | New 3-aryl propionic acid derivatives and analogs |
| MA26634A1 (fr) * | 1998-06-04 | 2004-12-20 | Astra Ab | Nouveaux derives de l'acide 3-aryl propionique et analogues |
-
2000
- 2000-11-29 AU AU20346/01A patent/AU2034601A/en not_active Abandoned
- 2000-11-29 WO PCT/SE2000/002379 patent/WO2001040165A1/en active Application Filing
- 2000-12-01 AR ARP000106383A patent/AR026704A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2034601A (en) | 2001-06-12 |
| WO2001040165A1 (en) | 2001-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR029412A1 (es) | Forma cristalina | |
| CL2004000382A1 (es) | Tetrahidroisoquinolinas sustituidas, proceso de preparacion, y composicion farmaceutica, utiles en el tratamiento y prevencion de estados patologicos que se alivian con un agonista de 5-ht6. | |
| ECSP066950A (es) | Combinaciones de glicopirrolato y agonistas del adrenoceptor-beta2 | |
| UY27300A1 (es) | Nuevos derivados de quinolina | |
| ECSP088869A (es) | Derivados de 2-pirazinona para el tratamiento de enfermedades o condiciones en donde resulta beneficiosa la inhibición de la actividad de la elastasa neutrofílica | |
| ECSP045483A (es) | Derivados de heteroarilamida benzocondensada de tienopiridinas útiles como agentes terapéuticos, composiciones farmacéuticas que incluyen a los mismos, y métodos para su uso | |
| ECSP055774A (es) | Nuevo medicamento para el tratamiento de la enfermedad pulmonar obstructiva crónica | |
| AR054347A1 (es) | Combinaciones terapeuticas para el tratamiento o la prevencion de la depresion | |
| SE0104334D0 (sv) | Therapeutic agents | |
| CO5271715A1 (es) | 7-aza-indolin-2-onas sustituidas en 4 y su uso como inhibidores de proteiuna quinasa | |
| AR056575A1 (es) | Compuesto de (alfa)-aminocarboxiamida que es 5-(4-[[(2-fluorofenil) metil] oxi] fenil)prolinamida, composicion farmaceutica que lo comprende, su uso para la fabricacion de un medicamento y proceso para prepararlo | |
| AR057712A1 (es) | Dihidropteridinonas en el tratamiento de enfermedades respiratorias | |
| AR029766A1 (es) | Compuesto inhibidor de quinasa y uso del mismo para preparar una composicion farmaceutica | |
| SE0401345D0 (sv) | Therapeutic compounds: Pyridine as scaffold | |
| AR029456A1 (es) | Forma triturada | |
| AR029211A1 (es) | Derivados de oxazoles, el uso de los mismos para la manufactura de un medicamento y composiciones farmaceuticas que los comprenden | |
| SE0302323D0 (sv) | Novel compounds | |
| ATE331711T1 (de) | Entzündungshemmende 3-arylthio-3- thiazolylalkylamine | |
| AR026704A1 (es) | Forma cristalina | |
| UY27018A1 (es) | Derivados de la pirimidina | |
| PA8581201A1 (es) | Nuevos derivados de tiazol | |
| AR001769A1 (es) | Benzamida enterocinética composiciones farmacéuticas que las contienen procedimiento para la preparación de dichas composiciones farmacéuticas el uso de dichos compuestos para la manufactura de medicamentos y un procedimiento para su preparación | |
| AR026705A1 (es) | Forma triturada | |
| ES2129448T3 (es) | Uso de 2-(2-nitro-4-trifluorometilbenzoil)-1,3-ciclohexanodiona en el tratamiento de tirosinemia y composiciones farmaceuticas. | |
| AR106180A2 (es) | COMPUESTO DE a-AMINOCARBOXIAMIDA QUE ES 5-(4-{[(2-FLUOROFENIL)METIL]OXI}FENIL)PROLINAMIDA |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |